Clinical trials
Phase 3 Nasopharyngeal Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
113 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 8 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 10 |
| 2021 | 6 |
| 2022 | 10 |
| 2023 | 13 |
| 2024 | 12 |
| 2025 | 13 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 43 |
| Unknown status | 33 |
| Active, not recruiting | 20 |
| Completed | 9 |
| Not yet recruiting | 7 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 56 |
| Fudan University | 6 |
| Jiangxi Provincial Cancer Hospital | 4 |
| Zhejiang Cancer Hospital | 4 |
| Eye & ENT Hospital of Fudan University | 3 |
| Ming-Yuan Chen | 3 |
| XIANG YANQUN | 3 |
| First Affiliated Hospital of Guangxi Medical University | 2 |
| Man Hu | 2 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Carcinoma | 113 |
| Nasopharyngeal Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Recurrence | 3 |
| Head and Neck Neoplasms | 2 |
| Nasopharyngeal Diseases | 2 |
| Pathologic Complete Response | 2 |
| Anorexia | 1 |
| Radiation Injuries | 1 |
| Thyroid Diseases | 1 |
Trials
Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.
13 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.